Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Revisão Bibliográfica
Vol. 15 No. 8 (2022), Revisão Bibliográfica
Vol. 15 No. 8 (2022)

A general approach to Attention Deficit Hyperactivity Disorder: a literature review

Published 2022-08-20
Enzo Garcia Bernardes
Emílio Conceição de Siqueira
PDF (Portuguese (Brazil))

Keywords

Attention Deficit Hyperactivity Disorder
Adults
Children

How to Cite

A general approach to Attention Deficit Hyperactivity Disorder: a literature review. (2022). Electronic Journal Collection Health, 15(8), e10864. https://doi.org/10.25248/reas.e10864.2022
ABNT ACM ACS AMA APA Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To analyze the characteristics of Attention Deficit Hyperactivity Disorder (ADHD). Bibliographic review: ADHD is characterized by persistent and disabling symptoms of age-inappropriate inattention and/or hyperactivity/impulsivity. It is one of the most common neurobehavioral disorders of childhood and can profoundly affect children's academic performance, well-being and social interactions. In addition to the core symptoms, emotional dysregulation (such as low frustration tolerance, irritability, ease of negative emotional experience, and emotional lability) independently contribute to functional impairments. Final considerations: ADHD is the most frequent neurobehavioral pathology in children and adolescents and has a high prevalence, as it affects about 5% of school-age children, while in adults the prevalence reaches 7.3% globally. It is characterized by early onset, a combination of hyperactive and poorly modulated behavior with marked inattention and persistent lack of task involvement, and scope over situations and persistence over time of these behavioral characteristics. The stimulant drugs Amphetamine (AMP) and Methylphenidate (MPH) are the first-line pharmacological treatment for ADHD and their effectiveness has been amply demonstrated.

PDF (Portuguese (Brazil))

References

ALBERDI-PARAMO I, PELAZ-ANTOLIN Emotionality and temperament in attention deficit disorder with or without hyperactivity. Rev Neurol, 2019; 69(8): 337-341.

ANDRÉS MM, et al. Isolated attention deficit disorder with/without hyperactivity in clinical practice. Series of cases. Arch Argent Pediatr, 2020; 118(4): e405-e409.

ARNS M, et al. Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed Guidelines. Appl Psychophysiol Biofeedback, 2020; 45(2): 39-48.

BEHESHTI A, et al. Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis. BMC Psychiatry, 2020; 20(1):120.

CHANG Z, et al. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts. Biol Psychiatry, 2020; 88(6): 452-458.

CHEN YL, et al. Correlations between Quality of Life, School Bullying, and Suicide in Adolescents with Attention-Deficit Hyperactivity Disorder. Int J Environ Res Public Health, 2020; 17(9): 3262.

CRUNELLE CL, et al. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. Eur Addict Res, 2018; 24(1): 43-51.

DANIELSON ML, et al. A National Profile of Attention-Deficit Hyperactivity Disorder Diagnosis and Treatment Among US Children Aged 2 to 5 Years. J Dev Behav Pediatr, 2017; 38(7): 455-464.

DEL-PONTE B, et al. Sugar consumption and attention-deficit/hyperactivity disorder (ADHD): A birth cohort study. J Affect Disord, 2019; 243: 290-296.

DRECHSLER R, et al. ADHD: Current Concepts and Treatments in Children and Adolescents. Neuropediatrics, 2020; 51(5): 315-335.

FARAONE SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev, 2018; 87: 255-270.

FARAONE SV, LARSSON H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry, 2019; 24(4): 562-575.

FRIEND AJ. Attention deficit hyperactivity disorder was associated with increased risk of suicidal behaviour. Arch Dis Child Educ Pract Ed, 2021; 106(1): 63.

GARAS P, BALAZS J. Long-Term Suicide Risk of Children and Adolescents with Attention Deficit and Hyperactivity Disorder-A Systematic Review. Front Psychiatry, 2020; 11: 557909.

GIUPPONI G, et al. Suicide risk in attention-deficit/hyperactivity disorder. Psychiatr Danub, 2018; 30(1): 2-10.

HIDA M, et al. Neuropsychological characteristics of adults with attention-deficit/hyperactivity disorder without intellectual disability. Neuropsychopharmacol Rep, 2020; 40(4): 407-411.

JAIN R, et al. Addressing Diagnosis and Treatment Gaps in Adults with Attention-Deficit/Hyperactivity Disorder. Prim Care Companion CNS Disord, 2017; 19(5): 17nr02153.

JANGMO A, et al. Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication. J Am Acad Child Adolesc Psychiatry, 2019; 58(4): 423-432.

JOHNSON J, et al. Attention deficit hyperactivity disorder in adults: what the non-specialist needs to know. Br J Hosp Med (Lond), 2020; 81(3): 1-11.

KAZDA L, et al. Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review. JAMA Netw Open, 2021; 4(4): e215335.

KATZMAN MA, et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry, 2017; 17(1): 302.

KATZENMAJER-PUMP L, et al. Low Level of Perfectionism as a Possible Risk Factor for Suicide in Adolescents with Attention-Deficit/Hyperactivity Disorder. Front Psychiatry, 2021; 12: 707831.

LÓPEZ-LÓPEZ A, et al. Treatment of attention-deficit/hyperactivity disorder in clinical practice. A retrospective study. Medicina (B Aires), 2019; 79(1): 68-71.

MAHONE EM, DENCKLA MB. Attention-Deficit/Hyperactivity Disorder: A Historical Neuropsychological Perspective. J Int Neuropsychol Soc, 2017; 23(9-10): 916-929.

MANOS MJ, et al. ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated? Cleve Clin J Med, 2017; 84(11): 873-880.

POSNER J, et al. Attention-deficit hyperactivity disorder. Lancet, 2020; 395(10222): 450-462.

POULTON A. Recognising attention deficit hyperactivity disorder across the lifespan. Aust J Gen Pract, 2021; 50(3): 110-113.

POZZI M, et al. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD). Expert Opin Emerg Drugs, 2020; 25(4): 395-407.

RUBIA K, et al. Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review. Cells, 2021; 10(8): 2156.

SIFFEL C, et al. Suicidal ideation and attempts in the United States of America among stimulant-treated, non-stimulant-treated, and untreated patients with a diagnosis of attention-deficit/hyperactivity disorder. J Affect Disord, 2020; 266: 109-119.

WOLRAICH ML, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics, 2019; 144(4): e20192528.

XUE J, et al. Meta-Analysis Study on Treatment of Children's Attention Deficit Disorder with Hyperactivity. J Healthc Eng, 2021; 2021: 8229039.

ZANG Y. Impact of physical exercise on children with attention deficit hyperactivity disorders: Evidence through a meta-analysis. Medicine (Baltimore), 2019; 98(46): e17980.